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JOABPEQ in different age and gender groups using data 
obtained from healthy volunteers.
Methods This study was conducted in 21 university hos-
pitals and affiliated hospitals from October 2012 to July 
2013. The JOABPEQ includes 25 questions that yield five 
domains to evaluate individuals with low back pain from 
five different perspectives. A total of 1,456 healthy vol-
unteers (719 men, 737 women; age range, 20–89 years) 
answered the questionnaire. The differences in scores 
according to age and gender were examined by non-para-
metric tests.
Results The JOABPEQ scores significantly decreased 
with age in the domains of lumbar spine dysfunction, gait 
disturbance, and social life dysfunction. In these three 
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administered questionnaire is a more accurate outcome 
measure for evaluating patients with low back pain, physi-
cians were unable to as certain the exact status of a patient 
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domains, the median scores approached the 100 possible 
points in individuals aged 20–70 for both genders. How-
ever, the median scores for lumbar spine dysfunction and 
social life dysfunction decreased to 83.0 and 65.0–78.0 
points, respectively, in individuals in their 80 s and 70–80 s, 
respectively; and the scores for gait disturbance decreased 
to 93.0 and 71.0 points for males and females in their 80 s. 
Overall, the median scores for pain-related and psychologi-
cal disorders were 100 and 60.0–72.0 points, respectively.
Conclusion The reference values for JOABPEQ accord-
ing to age and gender were established herein. Patients 
with low back pain should be evaluated with this new self-
administered questionnaire taking these reference values 
into account.
Introduction
In 1986, the Japan Orthopaedic Association (JOA) pub-
lished the JOA scoring system, a specific instrument to 
measure the outcomes of patients with low back pain 
(LBP) [1]. Since then, this instrument has been widely 
used to evaluate the clinical results of various surgical and 
nonsurgical interventions for patients with LBP [2–4]. 
However, a major criticism of the JOA score is that it is 
not a patient-oriented measurement, but rather a physician-
based one; and the patient’s perspective is now widely 
accepted to be essential for evaluating the results of inter-
ventions and making medical decisions [5]. The members 
of the subcommittee on evaluation for low back pain and 
cervical myelopathy, who also belong to the Clinical Out-
comes Committee of the JOA, have composed a new self-
administered questionnaire, the JOA Back Pain Evaluation 
Questionnaire (JOABPEQ), as a new outcome measure for 
patients with LBP [6–9] in order to solve the problems of 
the JOA score. The JOABPEQ provides specific, yet mul-
tidimensional, outcome measures for patients with LBP, 
including dysfunctions and disabilities caused by the dis-
ease, and psychosocial problems resulting from such dys-
functions and disabilities. The reliability and validity of the 
JOABPEQ have been verified by psychometric evaluations 
[7–9]. The scores for the JOABPEQ range from 0 to 100, 
with a higher score indicating a better health status. In clin-
ical practice, physicians have been able to evaluate treat-
ment efficacy by comparing patient scores before and after 
treatment, and to find better treatments by comparing the 
improvement rates among different treatment groups. How-
ever, physicians have been unable to ascertain the exact sta-
tus of a patient at a single time point based simply on the 
scores, when reference values have not been established. 
Additionally, the influence of age and gender on the scores 
has not been fully examined, and concerns have arisen that 
an age-related decline in the scores may influence the over-
all evaluation. Therefore, reference values of physically 
unimpaired individuals in different age and gender groups 
are needed to further validate this new self-administered 
questionnaire. Accordingly, this study aimed to establish 
reference values of the JOABPEQ by gender in healthy 
volunteers in their 20 s up to 80 s.
Participants and methods
This nationwide study was conducted in 21 university 
hospitals and their affiliated hospitals from October 2012 
to July 2013 (Fig. 1). During this period, the 2 weeks at 
the end and beginning of the year were excluded from the 
survey since the holiday season may have influenced the 
participants psychosocially. At the planning of the study 
design, the authors, who comprised 17 board-certified spine 
surgeons and a medical statistician, all of whom were mem-
bers of the Clinical Outcome Committee of the Japanese 
Society for Spine Surgery and Related Research, discussed 
and established the selection criteria of the participants. A 
summary of the selection criteria is shown in Table 1. The 
target population was healthy individuals who were self-
supporting and required no medical treatments for orthope-
dic diseases. The target age range was 20–89 years, and the 
participants were divided into groups according to gender 
(male/female) and age (20, 30, 40, 50, 60, 70, and 80 s). 
We aimed to survey five healthy individuals within each 
age group and from both genders (i.e., 5 persons × 7 age 
groups × both genders = 70 persons in total) at each insti-
tution in order to achieve a sufficient statistical power. The 
participants were recruited at each hospital by invitation 
of the research collaborators, who are all board-certified 
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orthopedic surgeons. Patients’ relatives, hospital employ-
ees, and persons concerned with the employees were candi-
dates for the study as long as the person was not a medical 
professional (e.g., physician, nurse, therapist, etc.).Subjects 
were excluded if they were unable to understand the ques-
tionnaire because of cognitive impairment, were under 
treatment for orthopedic disorders at a medical institution, 
had a history of previous lumbar surgery. However, sub-
jects with LBP were not excluded if they were judged to 
be able to perform daily their living activities unimpaired. 
Similarly, subjects receiving alternative medicine (e.g., acu-
puncture, massage, Judo therapy) were not excluded if the 
person was judged to be unimpaired. These two exceptions 
were made based on the following consensus after care-
ful discussions by the authors: (1) since the prevalence of 
LBP is very high [10, 11], an appreciable number of sub-
jects could potentially be prevented from participating if 
we excluded those who had mild LBP without an impact 
on activities of daily living, and as a result, the true status 
of the Japanese population might not be reflected; (2) Japa-
nese individuals receiving alternative medicines usually do 
not have severe medical conditions, because they perceive 
alternative medicines as more casual and receive them very 
often; and (3) thus, subjects with mild LBP and/or those 
who are receiving alternative medicine could be included 
if the person was able to perform their usual activities of 
daily living unimpaired. The eligibility was confirmed by 
the board-certified orthopedic surgeons at each institute.
This study was conducted in accordance with the World 
Medical Association Declaration of Helsinki [12], and 
approved by the institutional review board of each institu-
tion. All subjects provided informed consent prior to enroll-
ment in the study.
Self-administered questionnaires
JOABPEQ includes 25 questions that yield five domains: 
pain-related disorders, lumbar spine dysfunction, gait dis-
turbance, social life dysfunction, and psychological disor-
ders. Visual analogue scales (VASs) were used to evaluate 
the degree of LBP and pain or numbness in the buttocks 
and lower limbs with respect to the relevant items in the 
JOABPEQ. The participants recalled their physical con-
dition during the previous week and circled the number 
of the answer that best applied to their condition for each 
question. If the condition changed depending on the day or 
time, they were asked to select the answer representing the 
“worst” condition. The score of each domain was calcu-
lated according to the official guidelines and ranged from 0 
to 100 points, which is proportional to the patient’s clinical 
condition [7–9].
In addition, the participants were asked to respond to a 
question concerning the presence of LBP during the past 
month to evaluate its prevalence. In general, LBP is defined 
as pain and discomfort localized between the lowest cos-
tal margin and the inferior gluteal folds [13]. In the present 
study, however, the prevalence of LBP was examined by 
two different definitions as follows: LBP-A, the pain and 
discomfort localized between the costal margin and the 
iliac crest (therefore excluding the buttocks); and LBP-B, 
the pain and discomfort localized between the costal mar-
gin and the inferior gluteal folds. The LBP-A was exam-
ined for the purpose of maintaining consistency with the 
concepts of the JOABPEQ, in which VAS scores are used 
to separately evaluate the intensity of LBP and buttock 
pain; andthe LBP-B was examined in order to determine 
Fig. 1  Distribution of the twenty-one institutions that participated in 
this study
Table 1  Subject selection criteria
a
 Subjects with low back pain, judged to be able to perform daily 
their living activities unimpaired, were not excluded, even if they 
were receiving alternative medicine
Inclusion criteria
Age between 20 and 89 years
Self-supporting and requires no medical treatment for orthopedic 
diseasesa
Exclusion criteria
Cannot understand the questionnaire due to cognitive impairment
Under treatment for orthopedic disorders at a medical institutiona
Previous operation of the lumbar spine
Medical professionals (e.g., physician, nurse, therapist, etc.)
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the prevalence of LBP, thus allowing the results to be 
more readily compared to those of previous studies. To 
obtain information of both types of LBP, the participants 
were asked whether they had experienced LBP localized 
between the costal margin and the iliac crest and/or buttock 
pain localized between the iliac crest and the inferior glu-
teal folds that continued for more than 24 h during the past 
month. A schematic diagram explaining the definitions of 
LBP-A and buttock pain was provided with the question-
naire to the responders (Fig. 2). Moreover, the responders 
were provided the additional information that pain in the 
lower limbs did not include knee joint pain.
Statistical analysis
The functional score was calculated only if all questions for 
that particular domain were answered. Domains in which 
the participant did not answer all of the questions or pro-
vided inappropriate answers due to failure to follow instruc-
tions were excluded from the analysis. In the descriptive 
statistics, quartiles including median values were used for 
depicting the distribution of the scores of each domain in 
JOABPEQ, stratified by gender and age (i.e., 20–80 s), as 
the five functional scores have not been confirmed to fol-
low a normal distribution [9]. Similarly, the VAS scores 
were also described in a non-parametric manner because 
the normality of score distribution in the current study was 
denied by the Shapiro–Wilk test. The Steel–Dwass test was 
used for multiple comparisons among different genera-
tions, and the Jonckheere–Terpstra test was used to identify 
trends with regard to age for each domain. A p value <0.05 
was considered significant.
Results
A total of 1,469 healthy volunteers who were self-sup-
porting and received no medical treatments for orthopedic 
diseases answered the survey. Of these, 9 individuals were 
excluded because of age-related criteria (i.e., they were <20 
or >90 years old), and 4 individuals were excluded because 
of a lack of gender information. Thus, the answers of 1,456 
volunteers (719 males and 737 females) were used for the 
analysis. The number of subjects and prevalence of LBP in 
the different age groups according to gender are provided 
in Table 2. The prevalence of LBP-A and LBP-B were 
10.5 % (11.8 % in males, 9.2 % in females) and 11.5 % 
(12.6 % in males, 10.4 % in females), respectively.
Pain-related disorders
Overall, for both genders, the median score was 100. 
Among males, the first quartiles ranged between 71.0 
Fig. 2  The schematic diagram explaining the areas of low back pain 
and buttock pain for the responders
Table 2  Distribution of age, gender, and prevalence of low back pain in the 1,456 volunteers
Data are presented as n (%)
LBP-A low back pain defined as pain and discomfort localized between the costal margin and the iliac crest, LBP-B low back pain defined as 
pain and discomfort localized between the costal margin and the inferior gluteal folds
Age groups (years) Male Female
n LBP-A LBP-B n LBP-A LBP-B
20–29 106 16 (15.1 %) 17 (16.0 %) 126 9 (7.1 %) 9 (7.1 %)
30–39 107 8 (7.5 %) 9 (8.4 %) 104 3 (2.9 %) 3 (2.9 %)
40–49 109 11 (10.1 %) 11 (10.1 %) 110 5 (4.5 %) 5 (4.5 %)
50–59 109 12 (11.0 %) 12 (11.0 %) 105 11 (10.5 %) 14 (13.3 %)
60–69 99 12 (12.1 %) 12 (12.1 %) 98 10 (10.2 %) 11 (11.2 %)
70–79 97 15 (15.5 %) 18 (18.6 %) 100 15 (15.0 %) 17 (17.0 %)
80–89 92 11 (12.0 %) 12 (13.0 %) 94 15 (16.0 %) 18 (19.1 %)
Total 719 85 (11.8 %) 91 (12.6 %) 737 68 (9.2 %) 77 (10.4 %)
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and 85.5 in individuals in their 20–70 s, while it was 100 
in subjects in their 80 s. Among females, the first quar-
tiles ranged between 71.0 and 85.5 in individuals in their 
50–80 s, while it was 100 in individuals in their 20–40 s. 
For both genders, there were no significant differences in 
the scores between any age group (Fig. 3).
Lumbar spine dysfunction
For both genders, the median scores were 100 in subjects 
in their 20–70 s, while it was 83.0 in subjects in their 80 s. 
Among males, the first quartiles were all 100 in individuals 
in their 20–60 s, but decreased to 83.0 and 75.0 for those 
in their 70 and 80 s, respectively. Among females, the first 
quartiles were 100 in subjects in their 20–40 s, but this 
decreased to 83.0 in women in their 50–70 s, and further 
decreased to 67.0 points among those in their 80 s. Signifi-
cant differences were observed in the scores between the 
younger subjects in their 20 s and 30 s compared to sub-
jects in their 70 s(p < 0.05), and between individuals in 
their 20 s to 60 s compared to those in their 80 s (p < 0.05) 
in both genders (Fig. 4).
Fig. 3  Box and whisker plots of scores for pain-related disorders in 
the Japanese Orthopaedic Association Back Pain Evaluation Ques-
tionnaire by gender and age group. The lines on the box correspond to 
the quartiles. Whiskers indicate the furthest point within 1.5× inter-
quartile range from the box. There were no significant differences 
in the scores between any age groups in both genders (Steel–Dwass 
test). The scores had a tendency to increase with age in males and to 
decrease with age in females (Jonckheere–Terpstra test; p < 0.001 for 
both). N.S., not significant
Fig. 4  Box and whisker plots of scores for lumbar spine dysfunction 
in the Japanese Orthopaedic Association Back Pain Evaluation Ques-
tionnaire by gender and age group. The lines on the box correspond to 
the quartiles. Whiskers indicate the furthest point within 1.5× inter-
quartile range from the box. Significant differences were observed in 
the scores between the younger generation in their 20 and 30 s and 
subjects in their 70 s, and between subjects in their 20–60 s and those 
in their 80 s in both genders (Steel–Dwass test; *p < 0.05). The scores 
had a tendency to decrease with age in both genders (Jonckheere–
Terpstra test; p < 0.001)
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Gait disturbance
For males, the median scores were all 100 for subjects in their 
20–70 s, but this value decreased to 93.0 points for those in 
their 80 s. The first quartiles were 100 for subjects in their 
20–60 s, but decreased to 79.0 and 51.8 for those in their 
70 and 80 s, respectively. Significant differences were seen 
between male subjects in their 20–40 s and those in their 70 s, 
and between male individuals in their 20–60 s and those in 
their 80 s. For females, the median scores were 100 for sub-
jects in their 20–70 s and 71.0 in women in their 80 s. The 
first quartiles were 100 in their 20–50 s, but this decreased 
to 93.0, 79.0, and 43.0 in their 60, 70, and 80 s, respectively. 
Significant differences were observed in the scores between 
female subjects in their 40 vs. 60 s, in their 30 and 40 s vs. 
70 s, and in their 70 vs. 80 s (p < 0.05 for all; Fig. 5).
Fig. 5  Box and whisker plots of scores for gait disturbance in the 
Japanese Orthopaedic Association Back Pain Evaluation Question-
naire by gender and age group. The lines on the box correspond to the 
quartiles. Whiskers indicate the furthest point within 1.5× interquar-
tile range from the box. Significant differences were observed in the 
scores between younger subjects in their 20–60 s and elderly subjects 
in their 80 s for both genders, between male subjects in their 20–40 s 
vs. in their 70 s, between female subjects in their 40–60 s, in their 
30 s and 40 vs. 70 s, and in their 70 s vs. 80 s (Steel–Dwass test; 
*p < 0.05 for all). The scores had a tendency to decrease with age in 
both genders (Jonckheere–Terpstra test; p < 0.001)
Fig. 6  Box and whisker plots of scores for social life function in the 
Japanese Orthopaedic Association Back Pain Evaluation Question-
naire by gender and age group. The lines on the box correspond to 
the quartiles. Whiskers indicate the furthest point within 1.5× inter-
quartile range from the box. Significant differences were observed in 
the scores between subjects in their 20–60 s and those in their 80 s 
(Steel–Dwass test; *p < 0.05) in both genders. Moreover, a signifi-
cant difference in the scores between female subjects in their 30 and 
70 s was observed (Steel–Dwass test; *p < 0.05). The scores had a 
tendency to decrease with age in both genders (Jonckheere–Terpstra 
test; p < 0.001)
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Social life dysfunction
For males, the median scores were 100 for subjects in their 
20–60 s, but decreased to 78.0 and 75.5 for those in their 
70 and 80 s, respectively. The first quartile was highest for 
subjects in their 30 s, with a score of 86.0 points. The cor-
responding scores were 78.0 for subjects in their 20, 40, 50, 
and 60 s; and 70.0 and 51.0 in subjects in their 70 and 80 s, 
respectively. For females, the median scores were 100 for 
subjects in their 20–40 s, 92 for those in their 50 and 60 s, 
and 78.0 and 65.0 in subjects in their 70 and 80 s, respec-
tively. The first quartile was the highest for subjects in their 
30 s, with a score of 92.0 points. The corresponding values 
were 78.0 for subjects in their 20, 40, 50, and 60 s; but this 
decreased to 57.0 and 51.0 in individuals in their 70 and 
80 s, respectively. Significant differences were observed 
in the scores between the subjects in their 20–60 s com-
pared to those in their 80 s (p < 0.05) in both genders, and 
between females in their 30 vs. 70 s (p < 0.05) (Fig. 6).
Psychological disorders
For both genders, the median and the first quartile scores 
ranged between 60.0–72.0 and 49.0–60.0 across all genera-
tions, respectively. Moreover, the third quartile scores were 
72.0–83.5 points across all generations in both genders. 
There were no significant differences in the scores between 
any age group in both genders (Fig. 7).
Age trends among the various functional domains
Based on the results of the Jonckheere–Terpstra test, the 
scores tended to decrease with age in all domains in both 
genders, with the exception of the score for pain-related 
disorders, which showed a tendency to increase among 
males.
VASs
The median scores for all VAS score ranged between 0.0 
and 5.0 mm, with the majority being 0.0 mm in all age 
groups for both genders. For males, the third quartile 
values in the different age groups for LBP-A, pain in the 
buttocks and lower limbs, and numbness in the buttocks 
and lower limbs ranged between 17.0–27.0, 0.0–14.0, and 
0.0–8.0, respectively. For females, the three VAS domains 
ranged between 10.0–30.5, 0.0–29.0, and 0.0–13.0, 
respectively.
There were no significant differences in the VAS scores 
for LBP-A among different age groups in both genders, 
or for pain or numbness of the buttocks and lower limbs 
among different age groups in males. However, in females, 
significant differences in the VAS scores for pain in the but-
tocks and lower limbs were seen between subjects in their 
20–40 s and those in their 80 s. Further, a significant dif-
ference was seen in the VAS scores for numbness in the 
buttocks and lower limbs between female participants in 
their 20–30 s and those in their 80 s. The VAS scores of all 
regions tended to increase with age in both genders, with 
the exception of the VAS score for LBP in males, which did 
not change with age.
As described above, the overall prevalence of LBP-A 
was 10.5 %. The quartile value (median [first quartile–third 
quartile]) of the VAS score for LBP-A in the participants 
who responded “Yes” to the question asking the existence 
of LBP-A in the past month was 39 (20.5–58).
Fig. 7  Box and whisker plots of scores for psychological disor-
ders in the Japanese Orthopaedic Association Back Pain Evaluation 
Questionnaire by gender and age group. The lines on the box cor-
respond to the quartiles. Whiskers indicate the furthest point within 
1.5× interquartile range from the box. There were no significant dif-
ferences in the scores between any age groups in both genders (Steel–
Dwass test). The scores had a tendency to decrease with age in both 
genders (Jonckheere–Terpstra test, p < 0.001)
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Discussion
The purpose of this study was to provide reference values 
of the JOABPEQ in healthy adult populations who do not 
require medical assistance. We have established the ref-
erence values of JOABPEQ in the Japanese population 
for the first time, based on the data obtained from 1,456 
healthy volunteers recruited nationwide at 21 centers. The 
reference values should provide physicians with useful 
information on the status of a specific patient by comparing 
his or her scores with the reference values.
The JOABPEQ was designed to evaluate the overall 
health status (i.e., both physical and psychosocial disor-
ders) in patients with LBP, and may be suitable for follow-
ing changes in the status of each patient; however, it may 
unsuitable to directly compare such changes among differ-
ent patients [9]. Currently, a treatment is judged as “effec-
tive” for a particular patient if: (1) the patient provided 
answers to all the questions necessary to calculate a domain 
score and showed an increase of ≥20 points after the treat-
ment, or (2) the functional score after treatment exceeds 
90 points even if the answer for an unanswered question 
is assumed as the worst possible choice [9]. Our findings 
suggest that these values may require adjustment by age 
and gender. Moreover, the values obtained here for the vari-
ous age groups in both genders will serve as the reference 
when comparing scores of an individual or group to those 
of other individuals or groups.
The prevalence of degenerative diseases of the lumbar 
spine, including disc degeneration [14] and lumbar spi-
nal stenosis [15, 16], was reported to increase with age in 
population-based cohort studies in Japan. Similarly, the 
prevalence of osteoporosis was found to increase with age 
in the Japanese population and to lead to a surge in the inci-
dence of vertebral fractures in older subjects, especially in 
women, in other studies [17, 18]. Based on these reports, 
we assumed that physical function related to the lum-
bar spine would decline with age. The differences in the 
JOABPEQ scores according to age, sex, and disease type 
have been previously reported based on patient data [19]. 
Our findings are in conformity with these expectations, 
and indicate a need to establish reference values for newly 
developed questionnaires.
In the five domains of JOABPEQ, the scores for lumbar 
spine dysfunction, gait disturbance, and social life dysfunc-
tion decreased significantly with age, while the influence 
of aging was small for pain-related disorders and psycho-
logical disorders. Of particular note, the median scores for 
pain-related disorders were 100 points for all age groups in 
both genders. Meanwhile, the median scores for psycholog-
ical disorders were 60–70 points for all age groups in both 
genders, with the exception of males in their 60 s (median 
score: 72.0 points). Additionally, third quartile scores of 
>90 points were not observed in any age group for either 
gender in the domain of psychological disorders. Hence, a 
reconsideration is needed for judging the effectiveness of a 
treatment based on a score of >90 points for this domain.
Our study revealed that there are variations and differ-
ent trends in the reference values of scores for five domains 
of JOABPEQ in different age groups in both genders. This 
result is not surprising, as the JOABPEQ is partly derived 
from the Roland Morris Questionnaire and the MOS 
36-Item Short-Form Health Survey (SF-36) [6]. The SF-36 
is the most widely used survey to measure the health-
related quality of life, and the reference values for various 
parameters (e.g., general health perceptions, social func-
tioning) have been shown to vary considerably in Japanese 
adults [20]. Accordingly, the development of a norm-based 
scoring system similar to SF-36 [20] may be needed to fur-
ther understand the JOABPEQ scores.
Although VAS for LBP and pain or numbness in the but-
tocks and lower limbs are relevant items in the JOABPEQ, 
we did not statistically analyze the relationship between 
VAS values and JOABPEQ scores. The main reason for 
this was the purpose of this study, which was to establish 
the reference values of the JOABPEQ according to gender 
in healthy volunteers of different ages. Instead, we only 
presented the representative values of the VASs to pro-
vide a better understanding of the study population. Most 
of the VAS domains were significantly influenced by age. 
However, the median VAS values for LBP-A and pain or 
numbness in the buttocks and lower limbs were generally 
<10 mm, with most being 0 mm in all age groups for both 
genders. The third quartile VAS values for the three regions 
ranged between 0.0 and 30.5 across all generation in both 
genders. Collins et al. reported that 30–54 mm on the VAS 
was considered as moderate pain based on the distribution 
of VAS scores corresponding to a 4-point categorical scale 
(none, mild, moderate, and severe) [21]. Therefore, most 
of the participants in the current study did not have severe 
low back pain, which is consistent with the inclusion cri-
teria of our target population. Nevertheless, there is a pos-
sibility that subjects with LBP causing impairment might 
have been included in the study. However, we believe that 
reference values and statistical results provided here remain 
robust, because outliers do not easily affect the quartiles 
and the results of non-parametric tests. In the present study, 
11.5 % of the subjects fulfilled the definition for LBP-B, 
which is less than the 25.2 % prevalence rate estimated 
from 20,044 respondents of a recent Internet survey of the 
general Japanese population using the same definition [10]. 
The prevalence of LBP and the distribution of VAS scores 
would support the validity of our target population.
This study has several limitations. First, anthropomet-
ric data, including body mass index, exercise habits, the 
detailed medical history, and general health (e.g., mental 
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status) of the volunteers were not fully assessed, and the 
age-related degenerative changes of the lumbar spine were 
not investigated. Physical and mental conditions, therefore, 
may have affected the scores. Second, the data sampling 
was not randomized from the national resident record, and 
therefore the reference values acquired in this study are not 
population-based. Third, the physicians, who were aware 
of the selection criteria of this study, conducted the recruit-
ment of the participants. A selection bias may occur if the 
physicians had any expectations about the results. How-
ever, for this point, we believe that the pre-screening bias 
was minimized because this study was not a trial but rather 
a cross-sectional observational study. Fourth, the agree-
ment rate for the study participation among the candidates 
was not fully recorded, although we believe that it was 
almost 100 %, since the subjects were pre-screened by the 
physicians. The selection criteria for “healthy volunteers” 
and potential biases described above should be taken into 
account when using the values obtained in this study as ref-
erence values.
In conclusion, in this study, reference values of JOAB-
PEQ were established for healthy volunteers. Physicians 
should be aware that the JOABPEQ scores may vary by 
domain, gender, and age. The reference values derived 
herein from stratified sampling will help improve the 
understanding of the JOABPEQ scores, and may help iden-
tify the most appropriate treatments or medical services for 
patients with LBP.
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The JOA Back Pain Evaluation Questionnaire
With regard to your health condition during the last week, please circle the one item number of the answer for the
following questions that best applies. If your condition varies depending on the day or the time, circle the item
number of your condition at its worst.
Q1-1 To alleviate low back pain, you often change your posture.
1) Yes 2) No
Q1-2 Because of the low back pain, you lie down more often than usual.
1) Yes 2) No
Q1-3 Your lower back is almost always aching.
1) Yes 2) No
Q1-4 Because of the low back pain, you cannot sleep well.
(If you take sleeping pills because of the pain, select “No.”)
1) No 2) Yes
Q2-1 Because of the low back pain, you sometimes ask someone to help you when you do something.
1) Yes 2) No
Q2-2 Because of the low back pain, you refrain from bending forward or kneeling down.
1) Yes 2) No
Q2-3 Because of the low back pain, you have difficulty in standing up from a chair.
1) Yes 2) No
Q2-4 Because of the low back pain, turning over in bed is difficult.
1) Yes 2) No
Q2-5 Because of the low back pain, you have difficulty putting on socks or stockings.
1) Yes 2) No
Q2-6 Do you have difficulty in any one of the following motions; bending forward, kneeling or
stooping?
1) I have great difficulty 2) I have some difficulty
3) I have no difficulty
Q3-1 Because of the low back pain, you walk only short distances.
1) Yes 2) No
Q3-2 Because of the low back pain, you stay seated most of the day.
1) Yes 2) No
Q3-3 Because of the low back pain, you go up the stairs more slowly than usual.
1) Yes 2) No
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Q3-4 Do you have difficulty in going up the stairs?
1) I have great difficulty 2) I have some difficulty
3) I have no difficulty
Q3-5 Do you have difficulty in walking more than 15 minutes?
1) I have great difficulty 2) I have some difficulty
3) I have no difficulty
Q4-1 Because of the low back pain, you do not do any routine housework these days.
1) No 2) Yes
Q4-2 Have you been unable to do your work or ordinary activities as well as you would like?
1) I have not been able to do them at all.
2) I have been unable to do them most of the time.
3) I have sometimes been unable to do them.
4) I have been able to do them most of the time.
5) I have always been able to do them.
Q4-3 Has your work routine been hindered because of the pain?
1) Greatly 2) Moderately 3) Slightly (somewhat)
4) Little (minimally) 5) Not at all
Q5-1 Because of the low back pain, you get irritated or get angry at other persons more often than
usual.
1) Yes 2) No
Q5-2 How is your present health condition?
1) Poor 2) Fair 3) Good 4) Very good 5) Excellent
Q5-3 Have you been discouraged and depressed?
1) Always 2) Frequently 3) Sometimes 4) Rarely 5) Never
Q5-4 Do you feel exhausted?
1) Always 2) Frequently 3) Sometimes 4) Rarely 5) Never
Q5-5 Have you felt happy?
1) Never 2) Rarely 3) Sometimes 4) Almost always 5) Always
Q5-6 Do you think you are in decent health?
1) Not at all (my health is very poor)
2) Barely (my health is poor)
3) Not very much (my health is average health)
4) Fairly (my health is better than average)
5) Yes (I am healthy)
Q5-7 Do you feel your health will get worse?
1) Very much so 2) A little bit at a time
3) Sometimes yes and sometimes no 4) Not very much 5) Not at all
275Reference values for JOABPEQ
1 3
Regarding 0 as “no pain (numbness) at all” and 10 as “the most intense pain (numbness) imaginable,”
mark a point between 0 and 10 on the lines below to show the degree of your pain (numbness) when your
symptom was at its worst during the last week.
0 10
Degree of low back pain
Degree of pains in buttocks and lower limb
Degree of numbness in buttocks and lower limb
0: Comfortable condition without any pain at all
10: The most intense pain (numbness) imaginable
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